April 19, 2019
Researchers recently published the long-term outcomes of patients who received the investigational drug AVXS-101 – an adeno-associated virus serotype 9 mediated gene replacement therapy.
November 16, 2018
The model aims to provide the basis for many future studies to bring therapeutic options to patients with FSHD.
